Replicel video - David Hall interview
Collapse
X
-
Yes although I expect the results early 2017, as sometimes it seems to take a while for them to collect and analyze the data.
He also states that they consider their tendinosis product, as their lead product (Mr Hall says @ 50secs). Hopefully this won't distract them too much from the hair product.
Interestingly, by comparison, Histogen describe their own HSC hair product as their flagship product.
So maybe there is a comparison of company confidence in their own respective products. Or maybe that doesn't matter, time will tell.
Make of it what you willComment
-
i too can't see the video link.
currently, i'm using chrome on android.
as many others these days, most of the time i'm viewing the forum on the smartphone or on the tablet. thus, the forum should be made to work on all mobile end device as well.
thxComment
-
I think the video referenced is posted on Replicel's website. Good find, but I was disappointed that the CEO did not confirm that the next phase of trials has in fact started, nor an update as to Replicel's or Shiseido's timelines for commercialization.Comment
-
I'm using Opera 12.17 and I can see the embedded video clearly.
@James
Yeah I don't think the tendinosis as a flagship product is taking away from their commitment from their hair product.
They are already invested in Phase 2. The only thing I can see messing it up is Phase 2 results are shoddy or disappointing. Which could happen IMHO.Comment
-
I'm using Opera 12.17 and I can see the embedded video clearly.
@James
Yeah I don't think the tendinosis as a flagship product is taking away from their commitment from their hair product.
They are already invested in Phase 2. The only thing I can see messing it up is Phase 2 results are shoddy or disappointing. Which could happen IMHO.Comment
-
"our lead product is RCT-01"
The hairloss product, which is much further along in clinical trials than RCT-01 tendon treatment, is not their "lead product". WTF? Sounds like they have significantly changed their business strategy.Comment
-
@ joachim
Did you already see this? You could sign up for a clinical trial for replicel if you live in Germany or Austria without any problem.
however, i wouldn't like to participate in a double-blind placebo study, because it could be useless if you have the bad luck to get the placebo only. i would only participate if they could guarantee me that i will get the right solution injected.Comment
Comment